# Regenn® Therapy System Safety Study

> **NCT06259409** · PHASE1 · RECRUITING · sponsor: **Progenerative Medical, Inc** · enrollment: 30 (estimated)

## Conditions studied

- Surgical Wound

## Interventions

- **DEVICE:** Regenn® Negative Pressure Therapy System
- **DEVICE:** Prevena™ Incision Management System

## Key facts

- **NCT ID:** NCT06259409
- **Lead sponsor:** Progenerative Medical, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-09
- **Primary completion:** 2026-03
- **Final completion:** 2026-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06259409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06259409, "Regenn® Therapy System Safety Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06259409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*